Literature DB >> 21251810

Switching TGFβ from a tumor suppressor to a tumor promoter.

Gareth J Inman1.   

Abstract

TGFβ acts as a potent tumor suppressor and tumor promoter in a context dependent manner. Tumor suppressive functions include inhibition of cell proliferation, induction of apoptosis and regulation of autophagy. As tumors develop they switch their response to TGFβ and utilise this factor as a potent promoter of cell motility, invasion, metastasis and tumor stem cell maintenance. These multifactorial tumor influencing actions of TGFβ involve regulation of an increasing number of signal transduction pathways employing a diverse range of signaling molecules. Understanding the molecular mechanisms of how tumor cells respond to TGFβ and switch their response to this cytokine during disease progression is vital for both the development and the informed use of potentially powerful TGFβ targeted therapeutics.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21251810     DOI: 10.1016/j.gde.2010.12.004

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  99 in total

1.  Designing redox potential-controlled protein switches based on mutually exclusive proteins.

Authors:  Qing Peng; Na Kong; Hui-Chuan Eileen Wang; Hongbin Li
Journal:  Protein Sci       Date:  2012-08       Impact factor: 6.725

Review 2.  Epithelial delamination and migration: lessons from Drosophila.

Authors:  Federica Parisi; Marcos Vidal
Journal:  Cell Adh Migr       Date:  2011-07-01       Impact factor: 3.405

3.  Targeting the ERK pathway reduces liver metastasis of Smad4-inactivated colorectal cancer.

Authors:  Xi Ai; Yanhui Wu; Wei Zhang; Zhanguo Zhang; Guannan Jin; Jianping Zhao; Jingjing Yu; Youzhi Lin; Wanguang Zhang; Huifang Liang; Pran K Datta; Mingzhi Zhang; Bixiang Zhang; Xiaoping Chen
Journal:  Cancer Biol Ther       Date:  2013-09-12       Impact factor: 4.742

4.  Ras and Rho GTPases on the move: The RasGRF connection.

Authors:  Piero Crespo; Fernando Calvo; Victoria Sanz-Moreno
Journal:  Bioarchitecture       Date:  2011-07-01

5.  The ERK/CREB pathway is involved in the c-Ski expression induced by low TGF-β1 concentrations during primary fibroblast proliferation.

Authors:  Ping Li; Ping Liu; Yan Peng; Zhuo-Hang Zhang; Xiao-Ming Li; Ren-Ping Xiong; Xing Chen; Yan Zhao; Ya-Lei Ning; Nan Yang; Bo Zhang; Yuan-Guo Zhou
Journal:  Cell Cycle       Date:  2018-07-23       Impact factor: 4.534

Review 6.  The role of cytokines in breast cancer development and progression.

Authors:  Marcela Esquivel-Velázquez; Pedro Ostoa-Saloma; Margarita Isabel Palacios-Arreola; Karen E Nava-Castro; Julieta Ivonne Castro; Jorge Morales-Montor
Journal:  J Interferon Cytokine Res       Date:  2014-07-28       Impact factor: 2.607

7.  Birt-Hogg-Dubé: tumour suppressor function and signalling dynamics central to folliculin.

Authors:  Andrew R Tee; Arnim Pause
Journal:  Fam Cancer       Date:  2013-09       Impact factor: 2.375

8.  Expression of USP15, TβR-I and Smad7 in psoriasis.

Authors:  Ai-Ping Feng; Yi-Min He; Xin-Xin Liu; Jia-Wen Li; Ya-Ting Tu; Feng Hu; Shan-Juan Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-06-18

9.  Conditioned media from human ovarian cancer endothelial progenitor cells induces ovarian cancer cell migration by activating epithelial-to-mesenchymal transition.

Authors:  L Teng; S Peng; H Guo; H Liang; Z Xu; Y Su; L Gao
Journal:  Cancer Gene Ther       Date:  2015-10-23       Impact factor: 5.987

10.  Insights Into SMAD4 Loss in Pancreatic Cancer From Inducible Restoration of TGF-β Signaling.

Authors:  Paul T Fullerton; Chad J Creighton; Martin M Matzuk
Journal:  Mol Endocrinol       Date:  2015-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.